Jerry Kulangara John

Jerry John practices at Epiphany Dermatology PA in Austin, Texas.

Jerry John's NPI, 1285377457, was assigned on April 15, 2022.

Jerry John's primary practice is Epiphany Dermatology PA, at 7300 Ranch Rd 2222, Austin, TX 78730 in Travis County. The practice phone is (254) 537-1265.

Jerry John's primary practice is Epiphany Dermatology PA in Austin, Texas. The medical group on file is Epiphany Dermatology. Dmand AI also links Jerry John to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jerry John practices. Vendor and product names are available with a free account.

Physician assistant is Jerry John's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, minor injury to a limb, scalp rash, skin cyst and skin discoloration among the conditions Jerry John treats.

CMS data shows 1,293 Medicare services from Jerry John across 10 procedure codes in 2024, for 275 Medicare patients. Medicare paid $38,114 for them. Every service was in an office.

CMS counts 275 Medicare patients who saw Jerry John in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jerry John's median patient age at 58, with 49% women.

In 2024, Jerry John wrote 867 Medicare Part D claims for 355 patients. 96% of them were for generic drugs. CMS names the drug for 738 of them, across 14 drugs with 11 or more claims each, at $62,649 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Jerry John for performance year 2024, reported as part of a group. Jerry John accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 290 general payments to Jerry John from 25 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $923.